Shares of RXi Pharmaceuticals Corporation (OTC: RXII), a biotechnology company engaged in the discovery, development and commercialization of innovative therapies based on its proprietary, next-generation RNAi platform, surged in trading today.
Continue reading Micro-Cap on Watch; RXi Pharmaceuticals Corp. (RXII)